161 related articles for article (PubMed ID: 11478800)
1. Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.
Misumi S; Takamune N; Ido Y; Hayashi S; Endo M; Mukai R; Tachibana K; Umeda M; Shoji S
Biochem Biophys Res Commun; 2001 Aug; 285(5):1309-16. PubMed ID: 11478800
[TBL] [Abstract][Full Text] [Related]
2. A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine.
Misumi S; Nakajima R; Takamune N; Shoji S
J Virol; 2001 Dec; 75(23):11614-20. PubMed ID: 11689643
[TBL] [Abstract][Full Text] [Related]
3. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
Nakayama D; Misumi S; Mukai R; Tachibana K; Umeda M; Shibata H; Takamune N; Shoji S
J Biochem; 2005 Nov; 138(5):571-82. PubMed ID: 16272569
[TBL] [Abstract][Full Text] [Related]
4. A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression.
Misumi S; Endo M; Mukai R; Tachibana K; Umeda M; Honda T; Takamune N; Shoji S
J Biol Chem; 2003 Aug; 278(34):32335-43. PubMed ID: 12771150
[TBL] [Abstract][Full Text] [Related]
5. Cyclic zinc-dithiocarbamate-S,S'-dioxide blocks CXCR4-mediated HIV-1 infection.
Takamune N; Misumi S; Shoji S
Biochem Biophys Res Commun; 2000 Jun; 272(2):351-6. PubMed ID: 10833417
[TBL] [Abstract][Full Text] [Related]
6. Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.
Taub DD; Mikovits JA; Nilsson G; Schaffer EM; Key ML; Petrow-Sadowski C; Ruscetti FW
Cell Immunol; 2004 Aug; 230(2):65-80. PubMed ID: 15598422
[TBL] [Abstract][Full Text] [Related]
7. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
8. Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.
Khurana S; Kennedy M; King LR; Golding H
J Virol; 2005 Jun; 79(11):6791-800. PubMed ID: 15890918
[TBL] [Abstract][Full Text] [Related]
9. Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge.
Misumi S; Nakayama D; Kusaba M; Iiboshi T; Mukai R; Tachibana K; Nakasone T; Umeda M; Shibata H; Endo M; Takamune N; Shoji S
J Immunol; 2006 Jan; 176(1):463-71. PubMed ID: 16365439
[TBL] [Abstract][Full Text] [Related]
10. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
[TBL] [Abstract][Full Text] [Related]
11. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
Pontow S; Ratner L
J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).
Moss RB; Giermakowska WK; Diveley JP; Savary JR; Wallace MR; Maigetter RZ; Jensen FC; Carlo DJ
J Hum Virol; 2000; 3(1):44-9. PubMed ID: 10774806
[TBL] [Abstract][Full Text] [Related]
13. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
14. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
15. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4.
Wang J; Alvarez R; Roderiquez G; Guan E; Norcross MA
J Cell Biochem; 2004 Nov; 93(4):753-60. PubMed ID: 15660419
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
18. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
[TBL] [Abstract][Full Text] [Related]
19. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
20. Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides.
Zhang Y; Pool C; Sadler K; Yan HP; Edl J; Wang X; Boyd JG; Tam JP
Biochemistry; 2004 Oct; 43(39):12575-84. PubMed ID: 15449947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
